Danco Mifeprex Patent Extension Will Be Revised After Corcept Objects
Executive Summary
The patent life of Danco Labs/The Population Council's Mifeprex (mifepristone, RU-486) will be shortened following a determination by FDA that the abortifacient IND became "effective" in 1983 rather than 1994